TrialThe European respiratory journal2025
A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODY molecule.
Annemie Deiteren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled ittrialcites it